clinical trial markets

Prediction markets that resolve on pharmaceutical development milestones—trial endpoints, readouts, or FDA approval decisions—letting traders price the odds that a specific drug succeeds before results are public, with the attendant risks of influencing trial participants and sponsors.

Cluster: Business & Platforms

Related Concepts

• event contracts — Standardized binary contracts on specific real-world events, the core trading unit of prediction markets.
• insider trading — Trading on material non-public information (MNPI) obtained through a breach of a confidentiality duty or implied promise. In prediction markets, this arises when participants trade on privileged access to information about upcoming events, creating adverse selection for other traders.
• market manipulation — Deliberately trading to distort prices away from true probabilities for strategic or financial gain.
• information aggregation — The process by which markets combine dispersed private knowledge into a single consensus price signal.

Articles about clinical trial markets

• How Prediction Markets Could Distort Drug Approvals by Matt Motta, Timothy Callaghan, Michael Stein